COVID – 19 | Vaccination Update – Day 571

ad
Adults don't need tetanus, diphtheria boosters if fully vaccinated as children
Adults don't need tetanus, diphtheria boosters if fully vaccinated as children

India’s COVID-19 vaccination coverage has crossed207.01Crore(2,07,01,89,438)today. More than12lakh (12,08,200) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10412769
2nd Dose 10096476
Precaution Dose 6489537
FLWs 1st Dose 18432220
2nd Dose 17681274
Precaution Dose 12611395
Age Group 12-14 years 1st Dose 39601193
  2nd Dose 28851157
Age Group 15-18 years 1st Dose 61393685
  2nd Dose 51585964
Age Group 18-44 years 1st Dose 559904941
2nd Dose 510390498
Precaution Dose 35746147
Age Group 45-59 years 1st Dose 203767605
2nd Dose 195670987
Precaution Dose 22398464
Over 60 years 1st Dose 127495109
2nd Dose 122290507
Precaution Dose 35369510
Cumulative 1st dose administered 1021007522
Cumulative 2nd dose administered 936566863
Precaution Dose 112615053
Total 2070189438

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 9thAugust, 2022 (571stDay)
HCWs 1st Dose 23
2nd Dose 186
Precaution Dose 6374
FLWs 1st Dose 34
2nd Dose 298
Precaution Dose 13899
Age Group 12-14 years 1st Dose 17071
  2nd Dose 30836
Age Group 15-18 years 1st Dose 7311
  2nd Dose 19193
Age Group 18-44 years 1st Dose 14443
2nd Dose 62470
Precaution Dose 584831
Age Group 45-59 years 1st Dose 3420
2nd Dose 14156
Precaution Dose 292013
Over 60 years 1st Dose 2333
2nd Dose 9539
Precaution Dose 129770
Cumulative 1st dose administered 44635
Cumulative 2nd dose administered 136678
Precaution Dose 1026887
Total 1208200

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Be the first to comment

Leave a Reply